openPR Logo
Press release

Urinary Tract Infection Treatment Market is Expected to Reach US$ 10 Billion by 2022

05-03-2017 03:26 PM CET | Health & Medicine

Press release from: (MRE) Market Research Engine Reports

Urinary Tract Infection Treatment Market

Urinary Tract Infection Treatment Market

New York, May 03: Market Research Engine has published a new report titled as “Urinary Tract Infection Treatment Market: Global Industry Analysis and Forecast 2016 – 2022”

How Big is the Global Urinary Tract Infection Treatment Market?

The global urinary tract infection treatment market is expected to exceed more than US$ 10 Billion by 2022; Growing at a CAGR of more than 2% in the given forecast period.

Browse Full Report:

Urinary tract infection (UTI) arises in the kidneys, ureter, urethra and bladder because of microbial pathogens in these parts. Urinary tract infections will be uncomplicated or complicated depends on the severity of infection. The penicillin antibiotic that is amoxicillin is used to treat urinary tract infections and it is mainly used as prescribed antibiotic for uncomplicated urinary tract infection. UTI is common bacterial infections affecting many of peoples globally. Continuing urinary tract infection is a main health problem in females worldwide. Patients with spinal cord injury or urinary catheter are mainly contract complicated urinary tract infections.

The urinary tract infection treatment market is segmented on the lines of its drug type, indication, distribution channel and regional. Based on drug type segmentation it covers sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, aminoglycoside antibiotics, cephalosporin, quinolones and penicillin & combinations. Aminoglycoside antibiotics is further segmented into amikacin and gentamicin. Cephalosporin segmentation covers ceftriaxone, cefuroxime, cefixime and cephalexin. Under quinolones segmentation it covers ciprofloxacin, levofloxacin, nalidixic acid, norfloxacin and others. Penicillin and combinations covers amoxicillin, amoxicillin & clavulanate potassium and others.

The urinary tract infection treatment market is segmented on the lines of its indication like into complicated UTI, recurring complicated UTI, uncomplicated UTI and neurogenic bladder infections. Under distribution channel segmentation it covers hospital pharmacies, gynaecology and urology clinics, drug store, retail pharmacies and online drug stores. The urinary tract infection treatment market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for urinary tract infection treatment and related technologies.

2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for urinary tract infection treatment.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for Urinary Tract Infection Treatment Market for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnsons Private Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Inc., F.Hoffmann-La Roche Ltd., Novartis AG. and AstraZeneca plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Urinary Tract Infection Treatment Market has been segmented as below:

By Drug Type Analysis

• Sulphonamides
• Azoles and Amphotericin B
• Tetracycline
• Nitrofurans
• Aminoglycoside antibiotics
o Amikacin
o Gentamicin

• Cephalosporin

• Quinolones
Nalidixic acid

• Penicillin & Combinations
Amoxicillin & Clavulanate Potassium

By Indication Analysis

• Complicated UTI
• Recurring Complicated UTI
• Uncomplicated UTI
• Neurogenic Bladder Infections

By Distribution channel Analysis

• Hospital Pharmacies
• Gynaecology and Urology Clinics
• Drug Store
• Retail Pharmacies
• Online Drug Stores

By Regional Analysis

North America
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all urinary tract infection treatment .
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of urinary tract infection treatment data.
4) Assess your competitor’s refining portfolio and its evolution.


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urinary Tract Infection Treatment Market is Expected to Reach US$ 10 Billion by 2022 here

News-ID: 522509 • Views:

More Releases from (MRE) Market Research Engine Reports

Healthcare Mobility Solutions Market is Expected to Reach US$ 148.00 Billion by …
Healthcare mobility solutions market is segmented on lines of its application, product and service and end user analysis. The healthcare mobility market is segmented on the lines of its application like mobile devices, mobile applications (Apps) and enterprise mobility platforms. The mobile device is further segmented as mobile computers, RFID scanners and barcode scanners. Based on the end user the market is segmented by payers, providers and patients. Under provider
Wireless Health Market is Expected to Reach US$ 112.0 Billion by 2021
The wireless health market is segmented on the lines of its technology, component, application and end user. The wireless health market is segmented on the lines of its technology like WLAN/Wi-Fi, WPAN, WiMAX and WWAN. WPAN is further segmented into zigbee, Bluetooth, ant+, ultra-wide band (UWB), z-wave, RFID, RTLS, and IPS. WWAN is segmented into 3G and 4G, GPRS, CDMA and GPS. Under component segmentation it covers software, hardware and
Healthcare Analytics And Medical Analytics Market is Expected to Cross US$ 31 Billion by 2022
Healthcare Analytics And Medical Analytics Market is Expected to Cross US$ 31 Bi …
The Global Healthcare Analytics And Medical Analytics Market is segmented on the lines of its application, delivery mode, component, end user and regional. Based on application segmentation it covers clinical, financial, predictive modeling, operational and administrative and research. Under delivery mode segmentation it classified into on premise, web hosted and cloud based. Components are classified into hardware, software and services. Based on end user segmentation it covers healthcare, payers, providers
Mobile Virtual Network Operator (MVNO) Market is Expected to Exceed US$ 74 Billi …
The mobile virtual network operator market is segmented on the lines of its operational model, industry vertical, subscriber and regional. Based on operational model segmentation it covers full MVNO, service operator MVNO and reseller MVNO. Under industry vertical segmentation the mobile virtual network operator covers telecom, roaming, retail, migrant, media, M2M, discount and business. Based on subscriber segmentation it covers business and consumer. The mobile virtual network operator market’s geographic

All 5 Releases

More Releases for Urinary

Urinary Incontinence - Drug Pipeline Landscape, 2022
Urinary incontinence (UI) is the involuntary leakage of urine. UI happens when the muscles in the bladder that control the flow of urine contract or relax involuntarily, resulting in leaks or uncontrolled urination. The common causes of urinary incontinence include overactive bladder muscles, weakened pelvic floor muscles, nerve damage, interstitial cystitis (chronic bladder inflammation), obstruction, neurological disorders such as multiple sclerosis, stroke, or parkinson's disease. Urinary incontinence may also be caused
Urinary Incontinence Market Growing by Digital Therapeutic Device Improves Urina …
Demand Analysis of Urinary Incontinence Market Overview: The Urinary Incontinence Market is predicted to grow at a moderate CAGR of 8.42% during the forecast period covering 2020 to 2029. Urinary Incontinence Market share is estimated to reach a value of nearly US$ 6,718 million by 2029. The "Urinary Incontinence Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the
Urinary Incontinence Treatment Devices Market: High Prevalence of Urinary Incont …
The global urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe. The global market was valued at US$ 2.08 Bn in 2017 and is projected to expand at a CAGR of 7.4% from 2018 to 2026 to reach US$ 3.92 Bn by 2026. High growth of the market is attributed to increase in adoption, easy availability of electrical vaginal
Urinary Incontinence - Pipeline Review, H1 2018
"The Report Urinary Incontinence - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" About Urinary Incontinence Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Get Sample copy of this Report @ Urinary incontinence
Increasing Number of Surgical Procedures and Urinary Incontinence is Likely to D …
Urinary catheter is flexible tube, generally made up of silicone, latex or polyurethane, inserted through the tube that carries urine to collect the urine in a drainage bag. Urinary catheters are inserted by doctors or nurses through small opening created to a lower abdomen. With increased stress at workplaces and busy lifestyles of the people worldwide, the number of health disorders such as bladder dysfunction, kidney failure, chronic diseases and
Urinary Incontinence - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder’s contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk